KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Short term Debt (2016 - 2025)

Opko Health's Short term Debt history spans 16 years, with the latest figure at $10.3 million for Q4 2025.

  • For Q4 2025, Short term Debt fell 30.97% year-over-year to $10.3 million; the TTM value through Dec 2025 reached $10.3 million, down 30.97%, while the annual FY2025 figure was $10.3 million, 30.97% down from the prior year.
  • Short term Debt reached $10.3 million in Q4 2025 per OPK's latest filing, down from $12.8 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $33.5 million in Q4 2022 to a low of $10.3 million in Q4 2025.
  • Average Short term Debt over 5 years is $19.0 million, with a median of $17.8 million recorded in 2021.
  • Peak YoY movement for Short term Debt: surged 128.24% in 2022, then plummeted 46.78% in 2025.
  • A 5-year view of Short term Debt shows it stood at $14.7 million in 2021, then soared by 128.24% to $33.5 million in 2022, then dropped by 18.63% to $27.3 million in 2023, then crashed by 45.59% to $14.8 million in 2024, then crashed by 30.97% to $10.3 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Short term Debt are $10.3 million (Q4 2025), $12.8 million (Q3 2025), and $14.0 million (Q2 2025).